메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Alireza Sadeghi (Department of Internal Medicine School of Medicine Isfahan Iran) Somayeh Sadeghi (Infectious Diseases and Tropical Medicine Research Center Isfahan Iran) Mohammad Saleh Peikar (Department of Internal Medicine School of Medicine Isfahan Iran) Maryam Yazdi (Child Growth and Development Research Center Research Institute for Primordial Prevention of Non-Communicable Disease Isfahan Iran) Mehran Sharifi (Department of Internal Medicine School of Medicine Isfahan Iran) Safie Ghafel (Mycology Reference Laboratory Research Core Facilities Laboratory Isfahan Iran) Farzin Khorvash (Acquired Immunodeficiency Research Center Isfahan Iran) Behrooz Ataei (Infectious Diseases and Tropical Medicine Research Center Isfahan Iran) Mohammad Reza Safavi (Department of Anesthesiology School of Medicine Isfahan University of Medical Sciences Isfahan Iran) Elahe Nasri (Infectious Diseases and Tropical Medicine Research Center Isfahan Iran)
저널정보
대한혈액학회 Blood Research Blood Research Vol.58 No.2
발행연도
2023.6
수록면
91 - 98 (8page)
DOI
10.5045/br.2023.2022201

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background With the emergence of the coronavirus disease 2019 (COVID-19) and inability of healthcare systems to control the disease, various therapeutic theories with controversial responses have been proposed. Plasmapheresis was administered as a medication. However, the knowledge of its efficacy and indications is inadequate. This study evaluated the use of plasmapheresis in critically ill patients with cancer. Methods This randomized clinical trial was conducted on 86 patients with malignancies, including a control group (N=41) and an intervention group (N=45) with severe COVID-19 during 2020-21. Both groups were treated with routine medications for COVID-19 management according to national guidelines, and plasmapheresis was applied to the intervention group. C-reactive protein (CRP), D-dimer, ferritin, lactate dehydrogenase, hemoglobin, and white blood cell, polymorphonuclear, lymphocyte, and platelet levels were measured at admission and at the end of plasmapheresis. Other variables included neutrophil recovery, intensive care unit admission, intubation requirements, length of hospital stay, and hospitalization outcomes. Results CRP (P <0.001), D-dimer (P <0.001), ferritin (P =0.039), and hemoglobin (P =0.006) levels were significantly different between the groups after the intervention. Neutrophil recovery was remarkably higher in the case than in the control group (P <0.001). However, plasmapheresis did not affect the length of hospital stay (P=0.076), which could have significantly increased survival rates (P <0.001). Conclusion Based on the study findings, plasmapheresis led to a significant improvement in laboratory markers and survival rate in patients with severe COVID-19. These findings reinforce the value of plasmapheresis in cancer patients as a critical population suffering from neutropenia and insufficient immune responses.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0